WASHINGTON
The U.S. Food and Drug Administration (FDA) issued an emergency use permit Saturday for the Johnson & Johnson vaccine to combat the coronavirus.
The group said it had decided to have the third Janssen vaccine approved, that it met statutory criteria and that the known and potential benefits outweighed on the known and potential risks.
“The approval of this vaccine expands the availability of vaccines, the best medical prevention for COVID-19, to help us fight this pandemic,” the Commissioner said. FDA in action Janet Woodcock.
The vaccine is administered as a single dose.
“With today’s approval, we are adding another vaccine in our medical device box to fight this virus,” said Peter Marks, director of the FDA’s Center for Biological Assessment and Research.
President Joe Biden called the agreement “exciting news for all Americans, and a confident development in our efforts to end the crisis.”
“We know that the more people get the vaccine, the sooner we can catch the virus, get back to our friends and loved ones, and get our economy back on track. by the way, “the U.S. president said in a statement.
The other two vaccines administered in the US – one from Pfizer-BioNTech and another from Moderna – require two separate photos of each other weeks apart.
At the end of Saturday, nearly 73 million vaccine doses had been given nationwide.
The Anadolu Agency website contains only a portion of the news offered to subscribers in the AA News Broadcast System (HAS), and in summary form. Contact us for membership options.